[{"address1": "12730 High Bluff Drive", "address2": "Suite 400", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 500 8800", "website": "https://kuraoncology.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. Its lead product candidate includes ziftomenib, a selective investigational inhibitor of the menin-KMT2A interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; tipifarnib, an orally bioavailable farnesyl transferase inhibitor combination with alpelisib for patients with PIK3CA-dependent HNSCC; and KO-2806, a selective investigational FTI for the treatment of solid tumors. It has a clinical collaboration with Novartis Pharma AG to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression and/or PIK3CA mutation and/or amplification; strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize its oral menin inhibitor for the treatment of patients with acute myeloid leukemia (AML) and other hematologic malignancies; and a clinical collaboration with Mirati Therapeutics, Inc. to evaluate the combination of KO-2806 and adagrasib, a KRASG12C inhibitor in patients with NSCLC. The company is headquartered in San Diego, California.", "fullTimeEmployees": 192, "companyOfficers": [{"maxAge": 1, "name": "Dr. Troy Edward Wilson J.D., Ph.D.", "age": 55, "title": "Chairman, CEO & President", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 1296258, "exercisedValue": 1234936, "unexercisedValue": 15624}, {"maxAge": 1, "name": "Ms. Kathleen  Ford", "age": 77, "title": "Chief Operating Officer", "yearBorn": 1947, "fiscalYear": 2024, "totalPay": 868935, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Teresa Brophy Bair Esq., J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 745021, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas  Doyle", "age": 53, "title": "Senior Vice President of Finance & Accounting", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francis J. Burrows Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Roger  Bakale Ph.D.", "title": "Senior Vice President of Manufacturing & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Maureen  Clancy M.B.A.", "title": "VP and Global Head of Program Leadership & Project Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mollie  Leoni M.D.", "age": 46, "title": "Chief Medical Officer", "yearBorn": 1978, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian T. Powl M.B.A., M.S.", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Samir  Vattompadam M.S.", "title": "Senior Vice President of Global Program Leadership", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.44, "open": 8.53, "dayLow": 8.16, "dayHigh": 8.75, "regularMarketPreviousClose": 8.44, "regularMarketOpen": 8.53, "regularMarketDayLow": 8.16, "regularMarketDayHigh": 8.75, "payoutRatio": 0.0, "beta": 0.19, "forwardPE": -3.0898876, "volume": 2175724, "regularMarketVolume": 2175724, "averageVolume": 1613607, "averageVolume10days": 1765260, "averageDailyVolume10Day": 1765260, "bid": 8.08, "ask": 8.42, "bidSize": 3, "askSize": 44, "marketCap": 716076800, "fiftyTwoWeekLow": 5.41, "fiftyTwoWeekHigh": 21.11, "priceToSalesTrailing12Months": 8.598528, "fiftyDayAverage": 7.0994, "twoHundredDayAverage": 7.240775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 104821776, "profitMargins": -2.36761, "floatShares": 63935674, "sharesOutstanding": 86797185, "sharesShort": 8407325, "sharesShortPriorMonth": 7906891, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.09689999, "heldPercentInsiders": 0.01204, "heldPercentInstitutions": 0.95869005, "shortRatio": 4.6, "shortPercentOfFloat": 0.0971, "impliedSharesOutstanding": 88796150, "bookValue": 3.52, "priceToBook": 2.34375, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -197172000, "trailingEps": -2.25, "forwardEps": -2.67, "enterpriseToRevenue": 1.259, "enterpriseToEbitda": -0.479, "52WeekChange": -0.59178627, "SandP52WeekChange": 0.1653893, "quoteType": "EQUITY", "currentPrice": 8.25, "targetHighPrice": 40.0, "targetLowPrice": 11.0, "targetMeanPrice": 27.0, "targetMedianPrice": 27.0, "recommendationMean": 1.46667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 11, "totalCash": 630728000, "totalCashPerShare": 7.267, "ebitda": -218828000, "totalDebt": 19473000, "quickRatio": 5.928, "currentRatio": 6.159, "totalRevenue": 83279000, "debtToEquity": 6.374, "revenuePerShare": 0.954, "returnOnAssets": -0.22933, "returnOnEquity": -0.5111, "grossProfits": -114831000, "freeCashflow": -57676124, "operatingCashflow": 124987000, "grossMargins": -1.3788699, "ebitdaMargins": -2.6276503, "operatingMargins": -4.75314, "financialCurrency": "USD", "symbol": "KURA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_282774456", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1758323465, "regularMarketTime": 1758312001, "shortName": "Kura Oncology, Inc.", "longName": "Kura Oncology, Inc.", "regularMarketChangePercent": -2.25118, "regularMarketPrice": 8.25, "fiftyDayAverageChange": 1.1506, "fiftyDayAverageChangePercent": 0.16207002, "twoHundredDayAverageChange": 1.0092249, "twoHundredDayAverageChangePercent": 0.13938078, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1442410200000, "postMarketChangePercent": 1.2121258, "postMarketPrice": 8.35, "postMarketChange": 0.10000038, "regularMarketChange": -0.19, "regularMarketDayRange": "8.16 - 8.75", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1613607, "fiftyTwoWeekLowChange": 2.8400002, "fiftyTwoWeekLowChangePercent": 0.52495384, "fiftyTwoWeekRange": "5.41 - 21.11", "fiftyTwoWeekHighChange": -12.860001, "fiftyTwoWeekHighChangePercent": -0.60919, "fiftyTwoWeekChangePercent": -59.178627, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1754598600, "earningsCallTimestampEnd": 1754598600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.25, "epsForward": -2.67, "epsCurrentYear": -2.23256, "priceEpsCurrentYear": -3.6953096, "displayName": "Kura Oncology", "trailingPegRatio": null, "__fetch_time": "2025-09-20"}]